Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1594, 2007-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rosiglitazone and MI risk - will we ever know the answer?
Reactions Weekly, Vol. 1, Iss. 1158, 2007-01 ,pp. :
Access to resources
Recommend
Quantifying Adverse Drug Events: Are Systematic Reviews the Answer?
By Mahyar Etminan Bruce Carleton Paula A. Rochon
Drug Safety, Vol. 27, Iss. 11, 2004-01 ,pp. :
Increased risk of MI with tricyclics, but not SSRIs?
Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. :